Phase 1 Study of NGM313 in Healthy Adult Participants

A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity

NCT04707313 ·Status: COMPLETED ·Phase: PHASE2

Phase 1 to Study Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NA-931 in Obese Participants and Patients With Type 2 Diabetes Mellitus

NCT06615700 ·Status: COMPLETED ·Phase: PHASE1

Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Tablets in Non-diabetic Overweight or Obese Adult Subjects

NCT07166081 ·Status: RECRUITING ·Phase: PHASE1

Phase 2 Trials of NA-931 to Study Subjects Who Are Obese With at Least One Weight-related Comorbid Condition

NCT06564753 ·Status: COMPLETED ·Phase: PHASE2

A 2-Year Study of an Investigational Drug in Obese Patients (0557-011)

NCT00092859 ·Status: COMPLETED ·Phase: PHASE3

Phase II Study of THDBH120 Injection in Overweight or Obese Subjects

NCT07036601 ·Status: RECRUITING ·Phase: PHASE2

A Study of TG103 Injection in Overweight or Obesity

NCT05299697 ·Status: UNKNOWN ·Phase: PHASE2

A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED)

NCT00092872 ·Status: COMPLETED ·Phase: PHASE3

A Multiple Dose Study to Assess the Safety and Tolerability of BMS-963272 in Obese But Otherwise Healthy Adults

NCT04116632 ·Status: COMPLETED ·Phase: PHASE1

Single and Multiple Ascending Dose Study to Evaluate AMG 786 in Healthy Participants and Participants With Obesity

NCT05406115 ·Status: COMPLETED ·Phase: PHASE1

Single and Multiple Ascending Dose Study of AMG 133 in Participants With Obesity

NCT04478708 ·Status: COMPLETED ·Phase: PHASE1

Safety, Pharmacokinetics and Pharmacodynamics Study to Evaluate BMS-830216 in Obese Subjects

NCT00909766 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety Study to Evaluate BMS-830216 in Healthy Subjects

NCT00878020 ·Status: COMPLETED ·Phase: PHASE1

A Study of TG103 Injection in Non-diabetic Overweight or Obesity

NCT05997576 ·Status: COMPLETED ·Phase: PHASE3

First-in-Human Study of GM-60106 in Healthy Adults and Otherwise Healthy Adults With an Increased Body Mass Index and Markers of Non-Alcoholic Fatty Liver Disease

NCT05517564 ·Status: UNKNOWN ·Phase: PHASE1

Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Volunteers

NCT01444677 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1b Study to Evaluate the Safety of XEN-101

NCT06417697 ·Status: TERMINATED ·Phase: PHASE1

A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or Obesity

NCT06577766 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist

NCT06500429 ·Status: COMPLETED ·Phase: PHASE2

Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus

NCT07055516 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Pharmacokinetics, Safety, Tolerability and Efficacy of Intravenous Doses of ZGN-433 in Obese Female Volunteers

NCT01372761 ·Status: COMPLETED ·Phase: PHASE1

A Study of ZT002 Injection in Participants With Overweight or Obesity

NCT06371326 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese

NCT05616013 ·Status: COMPLETED ·Phase: PHASE2

A Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects

NCT00112021 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Pharmacodynamic Effects of a Single Oral Dose of GS-0976 (NDI-010976) in Healthy Adult Subjects

NCT02876796 ·Status: COMPLETED ·Phase: PHASE1